February 19, 2022 Comments Off on New patent for Amgen Inc drug LUMAKRAS Posted in: Patent Added Annual Drug Patent Expirations for LUMAKRAS Lumakras is a drug marketed by Amgen Inc and is included in one NDA. It is available from one supplier. The generic ingredient in…
The post New patent for Amgen Inc drug LUMAKRAS appeared first on DrugPatentW…
February 19, 2022 Comments Off on New patent for Vifor Fresenius drug VELPHORO Posted in: Patent Added Annual Drug Patent Expirations for VELPHORO Velphoro is a drug marketed by Vifor Fresenius and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent for Vifor Fresenius drug VELPHORO appeared first on Dr…
